Table 1.
Laboratory Data on Admission.
| Variable | Reference range | On admission |
|---|---|---|
| Erythrocyte count (×104/mm3) | 414-534 | 307 |
| Hemoglobin (g/dL) | 13.8-17.2 | 9.2 |
| Mean corpuscular volume (fL) | 83-100 | 92.4 |
| White blood cell count (/mm3) | 3,300-9,400 | 20,800 |
| White blood cell differential count (%) | ||
| Neutrophils | 37.5-66.0 | 88.5 |
| Lymphocytes | 19.5-47.0 | 4.5 |
| Monocytes | 2.2-10.4 | 6.0 |
| Eosinophils | 0-6.0 | 0.0 |
| Basophils | 0-1.8 | 0.0 |
| Platelet count (×104/mm3) | 18.0-39.0 | 15.8 |
| Erythrocyte sedimentation rate (mm/h) | 2-10 | 74 |
| PT (INR) | 0.87-1.15 | 1.21 |
| Activated partial thromboplastin time (s) | 25.0-35.0 | 27 |
| Fibrinogen (mg/dL) | 186-385 | 444 |
| FDP D-dimer (μg/mL) | 0.0-0.7 | 5.27 |
| Creatinine (mg/dL) | 0.68-1.04 | 0.56 |
| Urea nitrogen (mg/dL) | 8-20 | 14 |
| Creatine kinase (U/L) | 64-255 | 6 |
| Aspartate aminotransferase (U/L) | 14-32 | 10 |
| Alanine aminotransferase (U/L) | 11-45 | 8 |
| γ-glutamyl transpeptidase (U/L) | 10-58 | 129 |
| Alkaline phosphatase (U/L) | 112-334 | 875 |
| Lactate dehydrogenase (IU/L) | 125-225 | 101 |
| Total bilirubin (mg/dL) | 0.4-1.5 | 1.5 |
| Sodium (mEq/L) | 138-144 | 140 |
| Potassium (mEq/L) | 3.7-5.0 | 3.3 |
| Chloride (mEq/L) | 100-108 | 101 |
| C-reactive protein (mg/dL) | 0.0-0.20 | 8.77 |
| Total protein (g/dL) | 6.1 | 6.9-8.3 |
| Albumin (g/dL) | 4.1-5.1 | 2.3 |
| HbA1c (%) | 4.6-6.2 | 4.6 |
| Serum ferritin (ng/mL) | 25-280 | 302 |
| Procalcitonin (ng/mL) | 0.0-0.05 | 0.57 |
| Soluble interleukin-2 receptor (U/mL) | 145-519 | 5,369 |
| ACE (U/L) | 7.0-25 | 7.7 |
| BNP (pg/mL) | 0.0-18.4 | 110.8 |
| Haptoglobin (mg/dL) | 19-170 | 174 |
| IgG (mg/dL) | 870-1,700 | 1,666 |
| IgA (mg/dL) | 110-410 | 319 |
| IgM (mg/dL) | 33-190 | 113 |
| IgG4 (mg/dL) | 4.5-117 | <2.0 |
| C3 (mg/dL) | 70-129 | 153 |
| C4 (mg/dL) | 12-36 | 25 |
| Antinuclear antibody (n times) | 0-40 | <40 |
| Rheumatoid factor (IU/mL) | 0.0-15 | 329.8 |
| MPO-ANCA (U/mL) | 0-3.5 | <1.0 |
| PR3-ANCA (U/mL) | 0-3.5 | <1.0 |
| ASO (IU/mL) | 0.0-239 | 57 |
| HTLV-I/II antibody | Negative | Negative |
| β-D-glucan (pg/mL) | 0.0-11 | <6.0 |
| T-SPOT | Negative | Negative |
| Nil (negative control) | ≤10 | 0 |
| ESAT-6 | ≤5 | 0 |
| CFP10 | ≤5 | 0 |
| Mitogen (positive control) | ≥20 | 588 |
| HIV antigen antibody testing | Negative | Negative |
| Urinalysis | ||
| Uric protein | (-) | (1+) |
| Uric blood | (-) | (±) |
| Urinary sediment | ||
| Red cells (/HPF) | 0-4 | 1-4 |
| White cells (/HPF) | 0-4 | ≥50 |
| Albumin creatinine ratio (g/gCr) | 0.20 | |
| Non-acid-fast bacteria culture | ||
| Blood | Negative | Negative |
| Urine | Negative | Negative |
| Sputum | Negative | Negative |
| Subcutaneous abscess | Negative | Negative |
| Acid-fast bacteria culture | ||
| Blood | Negative | Negative |
| Gastric juice | Negative | Mycobacterium kansasii |
| Subcutaneous abscess | Negative | Mycobacterium kansasii |
PT: prothrombin time, INR: international normalized ratio, FDP: fibrin degradation products, HbA1c: hemoglobin A1c, ACE: angiotensin-converting enzyme, BNP: brain natriuretic peptide, Ig: immunoglobulin, MPO: myeloperoxidase, ANCA: antineutrophil cytoplasmic antibodies, ASO: antistreptolysin O, HTLV: human T-cell leukemia-lymphoma virus, HPF: high-power field